<DOC>
	<DOC>NCT01566188</DOC>
	<brief_summary>The overall aims of the present project are to investigate the impact of a nutritional approach based on omega-3 from vegetal origin on vascular function in hypertension associated with metabolic syndrome.</brief_summary>
	<brief_title>Vascular Impact of Omega-3 in Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>Female and male patients with treated essential hypertension (blood pressure values&lt;140/90 mmHg under antihypertensive treatment). Presence of at least two of the following criteria of the metabolic syndrome: abdominal girth &gt;102 cm in men or &gt;88 cm in women, HDLC&lt;0.4 g/L in men or &lt;0.5 g/L in women, fasting triglyceride &gt;1.5 g/L (or specific treatment for these lipid abnormalities), fasting glucose &gt;1.10 g/L. Secondary hypertension, myocardial infarction, coronary artery disease, cerebrovascular disease, stroke or transient ischemia, cardiac failure, diabetes (or fasting glucose&gt;1.26 g/L) or renal failure (MDRD &lt; 50 ml/min) Severe hypercholesterolemia (total cholesterol &gt; 2.5 g/l), alcohol or drug abuse, toxicomania, or clinically significant abnormalities in other current biological parameters.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>